Incidence des prescriptions hors autorisation de mise sur le marché en réanimation néonatale
- 1 February 2000
- journal article
- abstracts
- Published by Elsevier in Archives de Pédiatrie
- Vol. 7 (2) , 143-147
- https://doi.org/10.1016/s0929-693x(00)88083-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Unlicensed and off label drug use in neonates CommentaryArchives of Disease in Childhood: Fetal & Neonatal, 1999
- Unlicensed and off label drug use in paediatric wards: prospective studyBMJ, 1998
- Pediatric drug therapy in the emergency department: Does it meet FDA-approved prescribing guidelines?The American Journal of Emergency Medicine, 1997
- Physiology of the Neonatal Immune SystemJournal of Obstetric, Gynecologic & Neonatal Nursing, 1995
- Reproductive history and the risk of neonatal sepsisPaediatric and Perinatal Epidemiology, 1995
- Population pharmacokinetics of midazolam in neonatesClinical Pharmacology & Therapeutics, 1994
- Mechanisms of Unpredictable Adverse Drug ReactionsDrug Safety, 1994
- The Orphan Drug ActPublished by American Medical Association (AMA) ,1991
- Instrument or Impediment?Published by American Medical Association (AMA) ,1972
- Editorial comment: Therapeutic orphansThe Journal of Pediatrics, 1968